Tuesday, October 27, 2020
Home Life Style Health & Fitness Alzheimer's experimental drug shows new hope in treatment

Alzheimer’s experimental drug shows new hope in treatment

tablets-193666_640

New York: An experimental drug has been found to protect Alzheimer’s-inflicted mice from memory deterioration, despite a high-glycemic-index (GI) diet meant to boost blood sugar levels.

The experimental drug from the US-based Eli Lilly and Company mimics the hunger-signalling hormone ghrelin.

“The present results suggest that ghrelin might improve cognition in Alzheimer’s disease via a central nervous system mechanism involving insulin signalling,” authors of the study published in the journal Scientific Reports wrote.

“With chronic diseases like diabetes and Alzheimer’s, you need to do a long-term study,” said examiner Inga Kadish, assistant professor at University of Alabama School of Medicine at Birmingham.

“So we did an experiment with the worst-case scenario, a high GI diet. Alzheimer’s disease has 10 or 20 risk factors and some of the strongest risk factors are diabetes or metabolic syndrome.”

In contrast to short-term administration of the ghrelin agonista drug – which impairs insulin sensitivity and glucose tolerance, which are signs of metabolic syndrome and diabetes – the researchers found that the long-term ghrelin agonist treatment did not impair insulin signalling and glucose tolerance in Alzheimer’s disease mice fed with a high GI diet.

In the study, the Alzheimer’s disease-model mice showed a deterioration in spatial learning as they turned older — in other words, they got lost when trying to swim to a platform hidden just beneath the water surface that they previously were trained to find in a four-foot-wide pool.

The test mice fed with the ghrelin agonist and the high-GI diet showed long-term cognitive enhancement in this water maze test as compared to the mice fed with a normal diet or high-GI diet only.

The test mice also showed more activity, reduced body weight and fat mass. They also showed a beneficial impact of the long-term ghrelin agonist treatment on insulin signalling pathways in hippocampal brain tissue.

Alzheimer’s patients show significant shrinkage of the hippocampus, a part of the brain cortex that has a key role in forming new memories. (IANS)

STAY CONNECTED

19,120FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Books that Address Children’s Mental Health

In these unprecedented times, when isolation fatigue, gloom, and the fear of losing a beloved has also come to grip children, taking care of...

Air Pollution Linked to 15% of COVID Deaths Worldwide

In a major global study, researchers have revealed that long-term exposure to air pollution may be linked to 15 percent of COVID-19 deaths worldwide. According...

Ketogenic Diet could Prevent or Reverse Heart Failure

Heart problems? A special diet might help as researchers have found that the popular and controversial ketogenic diet could completely prevent, or even reverse...

Technology to Produce Psychoactive Drugs by IIT Guwahati

Indian Institute of Technology Guwahati (IIT-G) on Tuesday said its researchers have developed a low-cost membrane technology to produce psychoactive drugs and anti-aging compounds...

Fashion Hubs Burgeon into Fresh Farm Outlets

In recent days, people passing by some of the biggest fashion hubs in Mumbai rub their eyes in disbelief at what they behold. Instead of...

Weather Conditions for the Northeast Monsoon Fit Together

Weather conditions for the commencement of the northeast monsoon over parts of the extreme south peninsula are favorably falling in place as the withdrawal...

Buying Health Insurance Plans In India For Parents, Better Run Through These Pointers

 By Shubhi Gupta Many health insurance plans in India cover more than just the hospitalization charges. The best health insurance plans in India also cover...

5 Ways To Improve Your Career Prospects

By Carol Trehearn According to a national survey, 85% of American workers are unhappy in their jobs. While many people might have started out with...

Recent Comments